NBC: $MRNA Clears Another Step for Child Use

NBC News headline: FDA says Moderna’s Covid vaccine is effective, safe for young children

Subheadline: An FDA advisory committee will convene next week to review Moderna’s Covid vaccine for children ages 6 months to 17 years.


U.S. Food and Drug Administration staff reviewers on Friday said Moderna’s Covid-19 vaccine appears safe and effective for use in children aged 6 months to 17 years old as a committee of scientists will meet next week to vote on whether to recommend the regulator authorize the vaccine in children.

The FDA’s reviewers said in briefing documents published on Friday evening that the vaccine had generated a similar immune response in the children than that observed in adults in previous trials.